1 active not recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow Post COVID-19 Condition, Unspecified: new trials by email Literature Review of Post COVID-19 Condition, Unspecified trials Research Report on Post COVID-19 Condition, Unspecified
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Unknown | Erasmus Medical Center | 120 | 2024-10-01 | 2024-02-28 |
| PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway Nirmatrelvir/ritonavir, Placebo - Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection | Phase 3 | Active not recruiting | Haukeland University Hospital | 2000 | 2023-05-12 | 2025-11-21 |
COVID-19 (1) · Post-Acute COVID-19 Syndrome (1)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · COVID-19 (1) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1)
Hyperbaric Oxygenation (1) · nirmatrelvir and ritonavir drug combination (1)
Erasmus Medical Center (1) · Haukeland University Hospital (1)
Netherlands (1) · Norway (1)